Videos While Biogen rides a big-cap rollercoaster, a few small players are creating better trading opps. Articles You May Like UK 10-year borrowing costs hit highest level since 2008 Proton facilities default on payments Washington, D.C., revenue estimate boosted US set for IPO comeback as private equity firms seek to offload holdings Munis outperform UST losses, pushing ratios lower